(NEW YORK) — Here are today’s In Crisis headlines:
COVID-19 numbers
Here’s the latest data on COVID-19 coronavirus infections and deaths.
Latest reported numbers globally per Johns Hopkins University
Global diagnosed cases: 38,988,886
Global deaths: 1,099,380. The United States has the most deaths of any single country, with 217,717.
Number of countries/regions: at least 188
Total patients recovered globally: 26,930,074
Latest reported numbers in the United States per Johns Hopkins University
There are at least 7,980,934 reported cases in 50 states + the District of Columbia, Puerto Rico and Guam. This is more than in any other country.
U.S. deaths: at least 217,717. New York State has the greatest number of reported deaths in the U.S., with 33,337.
U.S. total patients recovered: 3,177,397
U.S. total people tested: 119,380,346
The greatest number of reported COVID-19 cases in the U.S. is in California, with 868,723 confirmed cases out of a total state population of 39.51 million. That ranks third in the world after Maharashtra, India, which has 1,564,615 reported cases, and Sao Paulo, Brazil, which has 1,051,613 reported cases.
US passes 217,000 COVID-19 deaths; CDC forecasts up to 240,000 by early November
The United States on Thursday surpassed 217,000 reported COVID-19 deaths, according to data compiled by Johns Hopkins University, with more than 20,000 additional deaths expected by the first week of November. The latest forecast from the Centers for Disease Control and Prevention estimates the U.S. will see a total of between 229,000 and 240,000 coronavirus deaths by the week ending November 7. The previous CDC forecast was for between 224,000 and 233,000 U.S. COVID-19 deaths reported by the week ending October 31.
US nears eight million COVID-19 cases as infections continue to surge nationally
The United States is on track to hit the grim milestone of eight million reported COVID-19 infections by early next week, if not over the weekend. As of Friday morning, Johns Hopkins University reported at least 7,980,934 reported cases in 50 states + the District of Columbia, Puerto Rico and Guam, which remains more than in any other country.
According to a Department of Health and Human Services memo obtained late Thursday by ABC News, 38 states and territories are in an upward trajectory of new cases, with 366,455 new cases confirmed during the period of Oct. 8-14 — a 16.4% increase from the previous seven-day period. Additionally, 24% of hospitals across the country have more than 80% of their ICU beds filled. That number was 17-18% during the summertime COVID-19 peak.
According to the Covid Tracking Project, the U.S. tallied 63,172 new cases on Thursday, the largest single-day total since late July. “After a month of warning signs, this week’s data makes it clear: The third surge of the COVID-19 pandemic in the United States is underway,” the Covid Tracking Project’s website declares.
Pfizer says they anticipate applying for COVID-19 vaccine approval before end of November
Pharmaceutical giant Pfizer, one of nearly a dozen companies currently in phase 3 human trials for a COVID-19 vaccine, said Friday they anticipate applying for emergency authorization use in the U.S. “in the third week of November.” Friday morning’s statement, issued under the name of Pfizer Chairman and CEO Albert Bourla, specifies three hurdles that must be cleared before that time: proof of effectiveness, proof of safety, and “manufacturing data that demonstrates the quality and consistency of the vaccine that will be produced.” “[A]ssuming positive data, Pfizer will apply for Emergency Authorization Use in the U.S. soon after the safety milestone is achieved in the third week of November,” the statement declares.
According to The New York Times, there are currently 11 ongoing phase 3 human trials of potential COVID-19 vaccines. Pharmaceutical giants Johnson & Johnson and Eli Lilly recently paused their phase 3 vaccine trials after a participant in each experienced an unexpected, unspecified illness.
Copyright © 2020, ABC Audio. All rights reserved.